Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NTLA
#2075
Intellia Therapeutics, Inc. - Common Stock
13.1
1
USD
-0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.61%
Monthly Change
+21.73%
6 month change
-5.03%
Year Change
-4.45%
Previous Close
13.1
9
Open
13.1
1
Low
13.1
1
High
13.1
1
Volume
210
Markets
US Stock Market
Healthcare
Biotechnology
NTLA
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2024
Current report, Q2 FY2024
2024.06.13
Intellia Therapeutics, Inc. current report, Q2 FY2024
8-K
Current report, Q2 FY2024
2024.06.14
Intellia Therapeutics, Inc. current report, Q2 FY2024
8-K
1
2
3
4
5
News
4 Gene-Editing Biotech Stocks Worth Watching for Long-Term Gains
Cathie Wood's ARK Goes On $27 Million SpaceX Shopping Spree
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q2 2026 Update (BATS:ARKK)
NTLA Q2 Earnings In Line, Top Line Misses on Lower Regeneron Revenues
Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Lags Revenue Estimates
Protagonist Therapeutics (PTGX) Beats Q2 Earnings Estimates
3 Promising Genomics Stocks to Add to Your Portfolio in 2026
Intellia Therapeutics: An Overvalued Biotech With Little To No Commercial Potential (NTLA)
Prime Medicine Beats Beam Therapeutics In Patent Dispute - But Both Are Investable (PRME)
NTLA Surges 38% in a Month: Should You Buy, Sell or Hold the Stock?
Wall Street Doubles Down on Wolfspeed Short Positions Over Cash Burn Fears
Strength Seen in Mirum Pharmaceuticals (MIRM): Can Its 5.5% Jump Turn into More Strength?